Esperion Therapeutics (ESPR) PT Raised to $7 at JPMorgan
Tweet
Share
E-mailGet Alerts ESPR Hot Sheet
Price: $3.18 --0%
Rating Summary:
6 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
6 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
JPMorgan analyst Jessica Fye raised the price target on Esperion Therapeutics (NASDAQ: ESPR) to $7.00 (from $6.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Sandvik AB (SAND:SS) (SDVKY) PT Raised to SEK440 at Rothschild Redburn
- Evolution Mining Ltd. (EVN:AU) (CAHPF) PT Lowered to AUD12.50 at RBC Capital
- Medco Energi Internasional Tbk PT (MEDC:IJ) PT Raised to IDR2,700 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
